###begin article-title 0
Enhanced pre-synaptic glutamate release in deep-dorsal horn contributes to calcium channel alpha-2-delta-1 protein-mediated spinal sensitization and behavioral hypersensitivity
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 95 96 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 101 102 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 373 374 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 379 380 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 385 387 369 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 593 594 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 602 603 586 587 <sc xmlns:xlink="http://www.w3.org/1999/xlink">D</sc>
###xml 925 926 905 906 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 931 932 907 908 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 937 939 909 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1363 1364 1335 1336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1369 1370 1337 1338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1375 1377 1339 1341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1438 1439 1402 1403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1444 1445 1404 1405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1450 1452 1406 1408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1824 1825 1780 1781 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1830 1831 1782 1783 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1836 1837 1784 1785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1888 1889 1836 1837 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1894 1895 1838 1839 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1900 1902 1840 1842 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2186 2187 2126 2127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 2192 2193 2128 2129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2198 2200 2130 2132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 336 351 <span type="species:ncbi:10090">transgenic mice</span>
###xml 421 436 <span type="species:ncbi:10090">transgenic mice</span>
###xml 809 824 <span type="species:ncbi:10090">transgenic mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1377 1392 <span type="species:ncbi:10090">transgenic mice</span>
Nerve injury-induced expression of the spinal calcium channel alpha-2-delta-1 subunit (Cavalpha2delta1) has been shown to mediate behavioral hypersensitivity through a yet identified mechanism. We examined if this neuroplasticity modulates behavioral hypersensitivity by regulating spinal glutamatergic neurotransmission in injury-free transgenic mice overexpressing the Cavalpha2delta1 proteins in neuronal tissues. The transgenic mice exhibited hypersensitivity to mechanical stimulation (allodynia) similar to the spinal nerve ligation injury model. Intrathecally delivered antagonists for N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxyl-5-methylisoxazole-4-propionic acid (AMPA)/kainate receptors, but not for the metabotropic glutamate receptors, caused a dose-dependent allodynia reversal in the transgenic mice without changing the behavioral sensitivity in wild-type mice. This suggests that elevated spinal Cavalpha2delta1 mediates allodynia through a pathway involving activation of selective glutamate receptors. To determine if this is mediated by enhanced spinal neuronal excitability or pre-synaptic glutamate release in deep-dorsal horn, we examined wide-dynamic-range (WDR) neuron excitability with extracellular recording and glutamate-mediated excitatory postsynaptic currents with whole-cell patch recording in deep-dorsal horn of the Cavalpha2delta1 transgenic mice. Our data indicated that overexpression of Cavalpha2delta1 in neuronal tissues led to increased frequency, but not amplitude, of miniature excitatory post synaptic currents mediated mainly by AMPA/kainate receptors at physiological membrane potentials, and also by NMDA receptors upon depolarization, without changing the excitability of WDR neurons to high intensity stimulation. Together, these findings support a mechanism of Cavalpha2delta1-mediated spinal sensitization in which elevated Cavalpha2delta1 causes increased pre-synaptic glutamate release that leads to reduced excitation thresholds of post-synaptic dorsal horn neurons to innocuous stimuli. This spinal sensitization mechanism may mediate at least partially the neuropathic pain states derived from increased pre-synaptic Cavalpha2delta1 expression.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 118 124 <span type="species:ncbi:9606">people</span>
###xml 387 395 <span type="species:ncbi:9606">patients</span>
Chronic pain derived from nerve injuries, or neuropathic pain, is a common clinical problem affecting over 50 million people in the United States [1]. Neuropathic pain may manifest as spontaneous pain, pain resulting from stimuli that are normally innocuous (allodynia), and increased pain responses to suprathreshold stimuli (hyperalgesia), all of which affect adversely the quality of patients' daily-life. Unfortunately, neuropathic pain tends to be long-term, and difficult to manage due to the poor efficacies and severe side effects associated with current conventional analgesic treatments. It appears that neuropathic pain with various etiologies can lead to similar behavioral endpoints that response differentially to pharmacological agents, suggesting that different mechanisms may underlie specific neuropathic pain states deriving from different pathological conditions. Thus, the development of target specific, safe and effective agents for neuropathic pain management relies on new insights into mechanisms of different neuropathic pain states.
###end p 4
###begin p 5
###xml 162 164 154 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 175 176 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 181 182 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 187 188 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 233 234 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 235 236 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 291 292 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 293 294 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 295 296 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 333 334 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 339 340 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 345 347 321 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 491 492 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 541 542 517 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 547 548 519 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 553 555 521 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 678 679 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 709 710 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 715 716 679 680 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 721 723 681 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 752 753 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 840 841 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 842 843 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 844 846 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 847 849 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 911 912 871 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 917 918 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 923 925 875 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1051 1052 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1104 1105 1056 1057 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1110 1111 1058 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1116 1118 1060 1062 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 485 489 <span type="species:ncbi:10116">rats</span>
###xml 508 523 <span type="species:ncbi:10090">transgenic mice</span>
###xml 799 807 <span type="species:ncbi:9606">patients</span>
Findings from previous studies have indicated that peripheral nerve injury induces a dramatic upregulation of the voltage-gated calcium channel (VGCC) alpha2delta1 subunit (Cavalpha2delta1) in sensory neurons and spinal dorsal horn [2-6], which correlates with neuropathic pain development [2,3,7]. Knocking down of injury-induced Cavalpha2delta1 upregulation in dorsal spinal cord with intrathecal antisense oligodeoxynucleotides results in allodynia reversal in spinal nerve injured rats [7]. In addition, transgenic mice overexpressing Cavalpha2delta1 in neuronal tissue display tactile allodynia similar to nerve injury models that can be blocked by intrathecal gabapentin [8], a drug that binds to the Cavalpha2delta1 proteins with high affinity [9] and has anti-neuropathic pain properties in patients and experimental animal models [2,3,10-16]. Furthermore, blocking axonal transport of injury-induced Cavalpha2delta1 from DRG neurons to their pre-synaptic terminals in spinal dorsal horn diminishes tactile allodynia in nerve-injured animals [7]. Together, these findings suggest that elevated Cavalpha2delta1 likely contributes to behavioral hypersensitivity through a pre-synaptic mechanism at the spinal cord level. This hypothesis, however, has not been tested directly.
###end p 5
###begin p 6
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 23 24 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 29 31 21 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 145 146 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 243 245 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 246 248 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 266 267 258 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 272 273 260 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 278 280 262 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 384 386 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 387 389 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 418 419 402 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 424 425 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 430 432 406 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 682 683 658 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 688 689 660 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 694 695 662 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 866 867 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 38 53 <span type="species:ncbi:10090">transgenic mice</span>
###xml 722 727 <span type="species:ncbi:10090">mouse</span>
Since elevated Cavalpha2delta1 in the transgenic mice has been shown to cause dorsal horn neuron hyperexcitability, behavioral hypersensitivity [8]; enhanced glutamate neurotransmission is an important mediator in neuropathic pain processing [17,18]; and elevated Cavalpha2delta1 may modulate various calcium channels that are known to regulate spinal pre-synaptic neurotransmission [19-25], we examined if elevated Cavalpha2delta1 mediated deep-dorsal horn neuron excitability and behavioral hypersensitivity through activation of glutamate receptors, and if so, whether it was mediated by a pre-synaptic or post-synaptic mechanism. We tested these hypotheses in the injury-free Cavalpha2delta1-overexpressing transgenic mouse model showing dorsal horn neuron hyperexcitability and behavioral hypersensitivity without the influence from other nerve injury factors [8].
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 100 101 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 106 108 98 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 108 123 <span type="species:ncbi:10090">transgenic mice</span>
A similar tactile allodynia state is developed in spinal nerve injured mice and injury-free Cavalpha2delta1 transgenic mice
###end title 8
###begin p 9
###xml 110 111 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 116 117 112 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 122 124 114 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 223 224 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 225 226 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 357 358 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 363 364 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 369 371 353 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 475 476 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 481 482 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 487 489 463 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 619 620 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 625 626 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 631 633 599 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 663 664 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 697 698 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 724 725 692 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 730 731 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 736 738 696 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 840 841 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 977 978 937 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 983 984 939 940 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 989 991 941 943 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1060 1061 1012 1013 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1066 1067 1014 1015 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1072 1074 1016 1018 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1300 1301 1244 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1302 1303 1246 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1304 1306 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1330 1331 1274 1275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1336 1337 1276 1277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1342 1344 1278 1280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1353 1354 1289 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
Our previous studies have indicated that unilateral spinal nerve ligation (SNL) induces upregulation of the Cavalpha2delta1 subunit in DRG and spinal dorsal horn that plays a critical role in tactile allodynia development [2,7]. However, nerve injury may also induce altered expression of other factors and activation of other pathways independent of the Cavalpha2delta1 induction, which may also contribute to tactile allodynia development. To determine if injury-induced Cavalpha2delta1 alone is sufficient to induce tactile allodynia, we examined the behavioral response of transgenic (TG) mice overexpressing the Cavalpha2delta1 proteins in neuronal tissues [8]. Similar to the SNL mice (Fig. 1 left), the injury-free Cavalpha2delta1 TG mice also developed a similar allodynic state compared with their wild-type (WT) littermates (Fig. 1, right). Since other factors in these two models, e.g. other injury-induced factors in the SNL model and compensatory factors in the Cavalpha2delta1 TG mice, are not likely the same, these data support that elevated Cavalpha2delta1 is highly likely a common factor mediating the abnormal sensations seen in these two models. This is supported by the findings that the tactile allodynia in both models can be blocked by treatment with intrathecal gabapentin [2,8,10], which binds to the Cavalpha2delta1 subunit [9].
###end p 9
###begin p 10
###xml 12 13 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 18 19 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 24 26 16 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 136 137 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 142 143 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 148 150 132 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 157 0 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased Ca<sub>v</sub>&#945;<sub>2</sub>&#948;<sub>1 </sub>expression in spinal cord and DRG correlates with tactile allodynia in spinal nerve ligated and injury-free Ca<sub>v</sub>&#945;<sub>2</sub>&#948;<sub>1 </sub>TG mice</bold>
###xml 384 385 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 390 391 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 396 398 372 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 713 715 687 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
Increased Cavalpha2delta1 expression in spinal cord and DRG correlates with tactile allodynia in spinal nerve ligated and injury-free Cavalpha2delta1 TG mice. Unilateral L5 spinal nerve ligation (SNL) surgeries were performed in mice, and paw withdrawal thresholds (PWT) to von Frey filament stimulation were measured two-weeks post injury in SNL mice or in injury-free, adult male Cavalpha2delta1 TG and WT mice as described in the Methods. Data presented are the means +/- SEM from n = 6 for the SNL group, and n = 12 each for the injury-free WT and TG groups. C - contralateral (non-injury) side. Ip - ipsilateral (injury) side. * p < 0.05 compared to contralateral side or WT control using unpaired Students' t test.
###end p 10
###begin title 11
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 83 84 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 89 90 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 91 106 <span type="species:ncbi:10090">transgenic mice</span>
A spinal glutamatergic pathway mediates behavioral hypersensitivity in the Cavalpha2delta1-transgenic mice
###end title 11
###begin p 12
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 31 32 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 37 38 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 188 190 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 191 193 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 194 196 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 316 318 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 319 321 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 405 406 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 411 412 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 417 418 401 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 628 629 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 637 638 621 622 <sc xmlns:xlink="http://www.w3.org/1999/xlink">D</sc>
###xml 729 730 713 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 735 736 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 741 743 717 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 757 759 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 857 859 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1138 1139 1114 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1225 1227 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
The pathway underlying Cavalpha2delta1-mediated behavioral hypersensitivity is not known. Since activation of glutamate receptors plays a role in central sensitization in pain processing [18,26-29] and activation of selective glutamate receptors is believed to play a critical role in SNL-induced tactile allodynia [17,18], we tested the hypothesis that glutamate receptor activation might underlie the Cavalpha2delta1-mediated behavioral hypersensitivity in the TG mice by examining the effects of intrathecal glutamate receptor antagonists on allodynia reversal in the TG mice. Intrathecal injection of memantine, a selective N-methyl-D-aspartate (NMDA) receptor antagonist, caused a dose-dependent allodynia reversal in the Cavalpha2delta1 TG mice (Fig. 2A). Its anti-allodynic effects at the highest dose tested (2 mg/kg) lasted for two-three hrs (Fig. 2B), and diminished completely overnight (data not shown). Similar drug treatment in the WT littermates led to a slight increase of behavioral thresholds to the same type of mechanical stimulation, which was not statistically significant compared with the pretreatment level (Fig. 2). The allodynia reversal by memantine was similar to that reported in the SNL model [17].
###end p 12
###begin p 13
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intrathecal NMDA receptor antagonists reverse tactile allodynia in the TG mice</bold>
###xml 395 396 395 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 580 583 578 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">## </sup>
###xml 593 597 591 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">### </sup>
###xml 736 737 734 735 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1026 1028 1022 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink">$ </sup>
###xml 1038 1042 1034 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">$$$ </sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 1089 1093 <span type="species:ncbi:10090">mice</span>
Intrathecal NMDA receptor antagonists reverse tactile allodynia in the TG mice. Memantine, an NMDA receptor antagonist, was injected intrathecally between L5/6 lumbar regions into adult TG and WT mice, and behavioral sensitivities to mechanical stimulation before or after drug treatments were assessed blindly as paw withdrawal thresholds (PWT) to von Frey filament stimulation in the hindpaw. A. Dose-dependent effects of intrathecal memantine for PWT in the TG and WT mice measured 120 min post i.t. injection. Data shown represent the means +/- SEM from n = 7 for each group. ## p < 0.01, ### p < 0.001 compared with WT mice, *** p < 0.001 compared with the pretreatment level using two-way ANOVA followed by Bonferroni post-tests. B. Time-dependent effects of intrathecal memantine (2.0 mg/kg) on allodynia reversal in TG mice compared with saline treatment and similar treatments in WT mice. Data shown represent the means +/- SEM from n = 7 for each group. * p < 0.05, ** p < 0.01 compared with the pretreatment level, $ p < 0.05, $$$ p < 0.001 compared with saline treatment in TG mice using two-way ANOVA followed by Bonferroni post-tests.
###end p 13
###begin p 14
###xml 396 397 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 443 445 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 670 671 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
Intrathecal injection of 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA receptor antagonist for the alpha-amino-3-hydroxyl-5-methylisoxazole-4-propionic acid (AMPA)/kainate receptors, at a dose of 50 mug/kg provided little allodynia reversal in the TG mice. However, intrathecal DNQX at a higher dose (0.15 mg/kg) provided a rapid onset and transient allodynia reversal in the TG mice (Fig. 3), similar to that reported in the SNL model [17]. Similar DNQX treatment in the WT littermates led to a slight increase of behavioral thresholds to the same type of mechanical stimulation, which was not statistically significant compared with the pretreatment level (Fig. 3).
###end p 14
###begin p 15
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intrathecal AMPA/kainate receptor antagonists reverse tactile allodynia in the TG mice</bold>
###xml 872 874 869 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">$ </sup>
###xml 884 888 881 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink">$$$ </sup>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
Intrathecal AMPA/kainate receptor antagonists reverse tactile allodynia in the TG mice. Different doses of DNQX, an antagonist of AMPA/kainate receptors, were injected intrathecally between L5/6 lumbar regions into adult TG and WT mice, and behavioral sensitivities to mechanical stimulation before or after drug treatments were assessed blindly as paw withdrawal thresholds (PWT) to von Frey filament stimulation in the hindpaw. Data shown are the dose- and time-dependent effects of intrathecal DNQX on allodynia reversal in TG mice compared with saline treatment or similar treatment in the WT mice. For the purpose of clarity, effects of the lower dose of DNQX (50 mug/kg) on PWT of WT mice, which were similar to that in saline treated WT mice, were not shown. Means +/- SEM from n = 7 for each group. ** p < 0.01, *** p < 0.001 compared with the pretreatment level, $ p < 0.05, $$$ p < 0.001 compared with saline treatment in TG mice using two-way ANOVA followed by Bonferroni post-tests.
###end p 15
###begin p 16
###xml 178 180 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 252 253 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 313 315 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
Intrathecal injection of 2-amino-3-phosphonopropionic acid (AP3), a non-competitive metabotropic glutamate receptor antagonist, at a maximum tolerable dose reported (50 mug/kg) [17], did not significantly reverse tactile allodynia in the TG mice (Fig. 4), which was in agreement with findings from the SNL model [17].
###end p 16
###begin p 17
###xml 0 107 0 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intrathecal antagonism of metabotropic glutamate receptors does not cause allodynia reversal in the TG mice</bold>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
Intrathecal antagonism of metabotropic glutamate receptors does not cause allodynia reversal in the TG mice. AP3, a mGluR antagonist, was injected intrathecally between L5/6 lumbar regions into adult TG and WT mice, and behavioral sensitivities to mechanical stimulation before or after drug treatments were assessed blindly as paw withdrawal thresholds (PWT) to von Frey filament stimulation in the hindpaw. Data shown are time-dependent effects of intrathecal AP3, at the maximum tolerable dose (50 mug/kg), on PWT of TG and WT mice. Means +/- SEM from n = 7 for each group.
###end p 17
###begin title 18
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 8 9 4 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 14 15 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Cavalpha2delta1-mediated spinal hyperexcitability through enhanced pre-synaptic glutamate release, but not likely through enhanced intrinsic excitability of dorsal horn neurons
###end title 18
###begin p 19
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 45 46 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 51 53 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 193 194 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 308 309 300 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 314 315 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 320 322 304 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 388 389 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 390 391 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 392 394 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 395 397 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 413 415 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 416 418 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 474 475 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 480 481 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 486 488 462 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 497 498 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 519 520 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 525 526 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 531 532 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 806 807 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
We reported previously that elevated Cavalpha2delta1 in the TG mice, without other injury induced factors, was sufficient to cause WDR neuron hyperexcitability and behavioral hypersensitivity [8]. Data from our previous studies have indicated that intrathecal injection of gabapentin, a drug that binds to Cavalpha2delta1 proteins and has anti-neuropathic pain efficacy in the SNL model [2,3,10-12] and patients [13-15], can reverse the behavioral hypersensitivity in the Cavalpha2delta1 TG mice [8], supporting that Cavalpha2delta1-mediated WDR neuron activation contributes at least partially to the behavioral hypersensitivity. Since the wind-up response, a phenomenon of progressively exaggerated WDR neuron excitability to repetitive C-fiber stimulation, is similar between the TG and WT littermates [8], the hyperexcitability of the TG dorsal horn neurons is not likely mediated by a facilitated state mediated by the wind-up mechanism.
###end p 19
###begin p 20
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 19 20 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 25 27 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 335 336 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 803 804 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 947 948 939 940 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 953 954 941 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 959 961 943 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
To test if Cavalpha2delta1 overexpression affects post-synaptic dorsal horn neuron excitability to acute stimuli, we compared C-fiber responses, post discharges, and non-potentiated responses (input) of WDR neurons from TG and WT littermates after brief transcutaneous electric stimulation with the C-fiber intensity. As shown in Fig. 5, similar levels of end point measures were observed between the TG and WT neurons. Even though our data do not allow the complete exclusion about possible influences from changes in strength of C-fiber synaptic inputs onto TG neurons, the occurrence of these changes, if any, would require opposite compensations in the excitability of TG neurons to maintain a level of excitability similar to that observed in WT mice, which are not supported by reported findings [8]. Thus, these findings suggest that the intrinsic excitability of WDR neurons, at least that to acute C-fiber inputs, is not changed in the Cavalpha2delta1 TG mice.
###end p 20
###begin p 21
###xml 0 106 0 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Similar excitability to high intensity electrical stimulation between WT and TG wide-dynamic-range neurons</bold>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
Similar excitability to high intensity electrical stimulation between WT and TG wide-dynamic-range neurons. Extracellular recordings were performed blindly to record dorsal horn single WDR neuron activity in response to C-fiber strength electrical stimulation applied to the receptive fields over the hindpaw of the WT and TG mice. Numbers of spikes from each neuron were pooled and the data are presented as the means +/- SEM from n = 10 in each group. C - C-fiber responses. PD - post discharge.
###end p 21
###begin p 22
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1306 1308 1292 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 1313 1315 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
This is further supported by our findings that elevated AMPA/kainate and NMDA receptor-mediated miniature excitatory postsynaptic currents (mEPSCs) in TG deep-dorsal horn neurons are at least partially mediated by enhanced pre-synaptic glutamate release, but not by changes in post-synaptic components, including enhanced intrinsic excitability of post-synaptic deep dorsal horn neurons. As shown in Fig. 6A and 6B, at a holding potential of -70 mV, the frequency of AMPA/kainate receptor mediated mEPSCs was significantly increased from 0.22 +/- 0.06 Hz for WT neurons (n = 7) to 0.79 +/- 0.08 Hz for the TG neurons (n = 9). Application of AMPA/kainate receptor antagonist CNQX (10 muM) could reduce mEPSCs by 91.3 +/- 5.3% and 93.9 +/- 3.3% in WT and TG neurons (n = 5 in each group, data not shown), respectively. In the presence of CNQX (10 muM), the frequency of NMDA receptor-mediated mEPSCs, recorded at a holding potential of +50 mV, was also increased in the TG neurons (WT: 0.03 +/- 0.02 Hz, n = 5; TG: 0.12 +/- 0.01, n = 3). However, the amplitudes of AMPA/kainate and NMDA receptor mediated mEPSCs were about the same between the WT and TG neurons. In addition, the kinetics of the AMPA/kainate and NMDA receptor mediated mEPSCs showed no obvious difference between the WT and TG neurons (Fig. 6C and 6D). The rising time of AMPA/kainate receptor mediated mEPSCs was 1.19 +/- 0.10 ms (n = 7) and 1.26 +/- 0.09 ms (n = 9) in WT and TG neurons, respectively, and the decay time constant was 5.05 +/- 0.43 ms (n = 7) and 5.12 +/- 0.39 ms (n = 9) in WT and TG neurons, respectively. The rising time of NMDA receptor mediated mEPSCs was 1.82 +/- 0.11 ms (n = 3) in WT and 1.70 +/- 0.05 ms (n = 3) in TG neurons, and the decay time constant was 15.13 +/- 0.34 ms (n = 3) in WT and 14.70 +/- 1.29 ms (n = 3) in TG neurons.
###end p 22
###begin p 23
###xml 0 133 0 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased frequency, but not amplitude, of AMPA/kainate- and NMDA-receptor mediated mEPSCs in deep-dorsal horn neurons of the TG mice</bold>
###xml 269 270 269 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 353 354 353 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 494 495 494 495 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 593 594 593 594 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
Increased frequency, but not amplitude, of AMPA/kainate- and NMDA-receptor mediated mEPSCs in deep-dorsal horn neurons of the TG mice. Spinal cord slices were prepared from the WT and TG mice, and spontaneous mEPSCs were recorded blindly from deep-dorsal horn neurons. A. Representative traces mediated by AMPA/kainate and NMDA receptors, respectively. B. Summarized mEPSC frequency (left) and amplitude (right) from WT and TG neurons mediated by AMPA/kainate and NMDA receptors, respectively. C. Representative traces of AMPA/kainite receptor mediated mEPSCs recorded from WT and TG neurons. D. Summarized mEPSC rising time (left) and decay time constant (right) from WT and TG neurons mediated by AMPA/kainate and NMDA receptors, respectively. Data presented are the means +/- SEM from the number of independent neurons indicated in the text. Statistic significance is indicated by p < 0.01 using unpaired Students' t test. n.s. - not significant
###end p 23
###begin title 24
Discussion
###end title 24
###begin p 25
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 97 98 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 103 105 95 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 147 148 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 149 150 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 151 152 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 177 178 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 183 184 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 189 190 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 396 397 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 398 399 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 400 402 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 534 535 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 540 541 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 546 548 522 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 690 691 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 696 697 668 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 702 704 670 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 972 973 940 941 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 978 979 942 943 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 984 986 944 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1260 1261 1220 1221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1266 1267 1222 1223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1272 1274 1224 1226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 1076 1080 <span type="species:ncbi:10090">mice</span>
While previous evidences have indicated a clear correlation between nerve injury-induced Cavalpha2delta1 upregulation and neuropathic pain states [3,4,7], pathways underlying Cavalpha2delta1-mediated behavioral hypersensitivity have not been identified. Since cellular changes in spinal cord and DRG after a prolonged peripheral nerve injury include altered expression of large numbers of genes [5,6,30], multiple factors induced by nerve injury may contribute to neuropathic hypersensitivity. In an attempt to study if upregulated Cavalpha2delta1 is sufficient to mediate behavioral hypersensitivity, and if so, what is the underlying mechanism, we have generated TG mice overexpressing Cavalpha2delta1 in neuronal tissues and compared their behavioral sensitivity to mechanical stimulation with the SNL model. Our data indicated that the TG mice have tactile allodynia similar to that observed in the SNL model. Since similar behavioral hypersensitivity and increased Cavalpha2delta1 expression occur in both models, and other factors such as compensatory changes in the TG mice and other injury-induced factors in the SNL model are not likely the same, our data, while do not allow the complete exclusion of other factors, strongly support that increased Cavalpha2delta1 proteins are sufficient in mediating tactile allodynia observed in these models.
###end p 25
###begin p 26
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 287 288 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 293 295 285 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 758 760 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
The pharmacology profiles in allodynia reversal by the spinally delivered, selective glutamate receptor antagonists are consistent with the pharmacology profiles of allodynia reversal by these agents in the SNL model as reported by others [17]. These data suggest that increased Cavalpha2delta1 mediates allodynia through a pathway related to a selective activation of AMPA/kainate and NMDA receptors. In contrast, metabotropic glutamate receptor antagonist, AP3, was without effect in allodynia reversal. This is consistent with the notion that metabotropic glutamate receptors are mainly involved in acute and persistent pain states associated with input from afferent C-fibers, but less so on tactile allodynia likely mediated by input from Abeta fibers [31].
###end p 26
###begin p 27
###xml 34 35 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 40 41 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 46 48 38 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 190 191 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 226 227 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 232 233 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 238 240 222 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 828 830 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
Since the TG mice have elevated Cavalpha2delta1 in different neuronal tissues ranging from DRG in the peripheral to spinal cord and supraspinal cord locations in the central nervous system [7], it is possible that increased Cavalpha2delta1 expression in peripheral as well as central locations in the TG mice contributes to the behavioral hypersensitivity through a glutamate receptor-dependent mechanism. Therefore, the enhanced dorsal horn neuronal excitability could derive from altered pre-synaptic neurotransmission, intrinsic post-synaptic neuron excitability or descending modulation from supra-spinal locations in the TG mice. While our data do not allow the exclusion of potential contributions to tactile allodynia by activated AMPA/kainate and NMDA receptors at supra-spinal locations in the TG mice, Chaplan et al. [17] reported that only spinal, but not i.c.v., injection of NMDA receptor antagonists reversed injury-induced allodynia in the SNL model. This suggests that activation of a spinal glutamatergic pathway is critical in the development of neuropathic pain states post peripheral nerve injury.
###end p 27
###begin p 28
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 517 518 517 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 523 524 519 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 529 531 521 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 705 706 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 711 712 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 717 719 701 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 769 770 753 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 775 776 755 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 781 782 757 758 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 937 938 913 914 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 943 944 915 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 949 951 917 919 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1029 1030 997 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1031 1032 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1073 1074 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1079 1080 1043 1044 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1085 1087 1045 1047 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1137 1138 1097 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1152 1153 1112 1113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1158 1159 1114 1115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1164 1166 1116 1118 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1175 1176 1127 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1195 1196 1147 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1201 1202 1149 1150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1207 1209 1151 1153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1422 1423 1363 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1499 1500 1440 1441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1505 1506 1442 1443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1511 1513 1444 1446 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1581 1582 1514 1515 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1587 1588 1516 1517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1593 1595 1518 1520 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1761 1762 1686 1687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1844 1845 1769 1770 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1850 1851 1771 1772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1856 1858 1773 1775 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1870 1871 1787 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 2100 2102 2017 2019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
###xml 1616 1620 <span type="species:ncbi:10090">mice</span>
Data from this study further demonstrate that, in contrast to the enhanced excitability of TG WDR neurons to natural stimuli reported previously [8], acutely evoked excitability of WDR neurons to C-fiber-strength electric stimulation is not altered in the TG mice. While mechanisms underlying this discrepancy are not clear, the simplest explanation is that detected WDR neuron excitability to natural stimuli derives from neuronal activation by inputs from multiple sensory fibers including A-fibers, and elevated Cavalpha2delta1 expression results in a higher excitability of the WDR neuron to A-fiber-, but not C-fiber-, strength stimulation (see discussion below). Thus, it is likely that increased Cavalpha2delta1 expression mediates tactile allodynia through a Cavalpha2delta1-dependent pathway by enhancing synaptic strength of A-fibers. Indeed, this hypothesis is consistent with reported findings that: (a) The basal level of Cavalpha2delta1 expression is relatively high in small DRG neurons, low in large DRG neurons [6,8], and there is a dramatic increase in Cavalpha2delta1 expression in large DRG neurons after SNL injury [6] or in the Cavalpha2delta1 TG mice [8]; (b) increased Cavalpha2delta1 expression correlates with development of allodynia mainly mediated by large Abeta fibers, but not formalin- and carrageenan-induced acute pain states mainly mediated by nociceptive C-fiber inputs in the TG mice [8], and formalin- or carrageenan-induced pain models do not have increased Cavalpha2delta1 expression in DRG and spinal cord (data not shown); (c) increased Cavalpha2delta1 expression in the TG mice does not alter the receptive field sizes of WDR neurons, nor the excitability of these neurons to repetitive C-fiber stimulation (wind-up) [8]; (d) In the model of sciatic nerve chronic constriction injury with increased Cavalpha2delta1 expression [3], a subpopulation of dorsal horn neurons exhibits abnormal afterdischarges to mechanical and thermal stimuli, but the number of dorsal horn neurons showing wind-up phenomenon to repetitive C-fiber stimulation remains unchanged [32].
###end p 28
###begin p 29
###xml 153 154 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 159 160 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 165 167 157 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 810 811 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 816 817 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 822 824 806 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1105 1106 1089 1090 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1111 1112 1091 1092 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1117 1119 1093 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 1241 1245 <span type="species:ncbi:10090">mice</span>
The increase in frequency of AMPA/kainate and NMDA receptor mediated mEPSCs in deep dorsal horn neurons from the TG mice suggests that elevated spinal Cavalpha2delta1 proteins lead to an increased rate of quanta release of excitatory neurotransmitter glutamate from pre-synaptic terminals at the resting state, which in turn, enhances excitability of post-synaptic dorsal horn neurons through mainly AMPA/kainate receptor activation. Since the deep dorsal horn neurons for in vitro and vivo recordings were selected from a similar dorsal horn lamina, and very few non-WDR neurons (which were excluded) were detected in this lamina during neuron sampling in vivo, it is highly likely that a similar population of WDR neurons was examined in our in vivo and in vitro recording. Our data indicate that elevated Cavalpha2delta1 proteins do not change the amplitudes of AMPA/kainate and NMDA receptor-mediated mEPSCs. This suggests that neither the quantum size of glutamate release nor the intrinsic excitability of post-synaptic dorsal horn neurons to glutamate receptor activation is changed by increased Cavalpha2delta1 expression. Direct measurements of glutamate release in deep dorsal horn and membrane excitability of WDR neurons from TG mice would further help to clarify these issues.
###end p 29
###begin p 30
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 1235 1237 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1535 1537 1535 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1858 1860 1858 1860 <sub xmlns:xlink="http://www.w3.org/1999/xlink">B </sub>
###xml 1975 1977 1975 1977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 2227 2228 2224 2225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 2233 2234 2226 2227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2239 2241 2228 2230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 680 695 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
###xml 1637 1641 <span type="species:ncbi:10090">mice</span>
###xml 2119 2123 <span type="species:ncbi:10090">mice</span>
It remains elusive that AMPA/kainate receptor antagonists only normalize behavioral hypersensitivity in the TG mice without affecting the behavioral sensitivity in the WT mice significantly. It is likely that binding of glutamate to AMPA receptors at a resting state causes a conformational change of the receptors that is linked to channel opening followed by desensitization of the receptors, a mechanism controlling glutamate-induced neuron activation under normal physiological conditions [33]. It is possible that DNQX has lower binding affinity to AMPA receptors at the conformation under physiological conditions, thus, is less effective in blocking AMPA receptors. In the transgenic mice or under a pathological condition in which pre-synaptic glutamate release is enhanced, the AMPA receptor channels could be in a different conformational state due to partial membrane depolarization and channel opening [33], a primed state as suggested in Fig. 7B. DNQX could have a higher affinity to this state, thus, be more effective in blocking AMPA receptors in the TG mice or pathological conditions. Alternatively, glutamate activation of kainate receptors at the pre-synaptic sensory neuron terminals can reduce glutamate release [34], and that at spinal interneurons can induce inhibitory transmitter release [35], which together help to terminate transient activation of post-synaptic dorsal horn neurons under normal physiological conditions. This heterosynaptic regulation is transient due to kainate receptor desensitization [35]. It is possible that this heterosynaptic regulation is less sensitive to DNQX. However, in the TG mice or under a pathological condition in which pre-synaptic glutamate release is enhanced, prolonged activation of kainate receptors at inhibitory interneurons can enhance GABA release that may activate pre-synaptic GABAB autoreceptors, which in turn, reduces potential-dependent inhibitory transmitter release and causes disinhibition [35]. It is possible that DNQX is more effective in blocking this prolonged activation of kainate receptors. Finally, it is possible that the WT mice are relatively insensitive to (Abeta-mediated) mechanical stimulation, possibly due to the low level Cavalpha2delta1 expression in large neurons as discussed previously, so that it is difficult to detect any change in mechanical sensitivity. These possibilities may be not mutually exclusive.
###end p 30
###begin p 31
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 30 31 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 36 37 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 0 70 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Proposed mechanism of Ca<sub>v</sub>&#945;<sub>2</sub>&#948;<sub>1</sub>-mediated spinal hypersensitivity</bold>
###xml 157 158 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 163 164 151 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 169 170 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 205 206 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 239 240 223 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 245 246 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 251 253 227 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 637 638 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 643 644 615 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 649 651 617 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 843 844 811 812 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 896 897 864 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 902 903 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 908 909 868 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1542 1543 1502 1503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1548 1549 1504 1505 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1554 1556 1506 1508 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1654 1655 1606 1607 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1703 1704 1655 1656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1709 1710 1657 1658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1715 1716 1659 1660 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Proposed mechanism of Cavalpha2delta1-mediated spinal hypersensitivity. A model of enhanced spinal glutamate release illustrates the possible mechanism of Cavalpha2delta1-mediated spinal hypersensitivity. A. Under normal conditions, the Cavalpha2delta1 expression level and quantum release of excitatory neurotransmitter glutamate from pre-synaptic A-fiber terminals is low so that post-synaptic deep dorsal horn neurons maintain a normal excitation threshold. As a consequence, glutamate release in response to stimuli results in a physiological activation of deep dorsal horn neurons mainly by activating AMPA/kainate receptors. The Cavalpha2delta1 expression level at C-fiber terminals is relatively high (causing a ceiling effect for C-fiber activation), but there is little C-fiber input onto deep dorsal horn neurons at a resting state. B. Under a pathological condition with an elevated Cavalpha2delta1-level at the A-fiber pre-synaptic terminals, such as post peripheral nerve injuries, the quantum release of glutamate from these terminals at a resting membrane potential is dramatically enhanced. This glutamate "leaking" causes a partial depolarization of post-synaptic deep dorsal horn neurons by activating AMPA/kainate receptors. As a consequence, these primed deep dorsal horn neurons have lowered excitation thresholds to subsequently evoked glutamate release, and also hyperexcitability due to lowered thresholds to NMDA receptor activation. Neither the partial depolarization of deep dorsal horn neurons nor the increased Cavalpha2delta1 expression in C-fiber terminals has any detectable effect to high intensity C-fiber stimulations. C. Proposed potential mechanisms mediating the Cavalpha2delta1-enhancement of spinal glutamate release.
###end p 31
###begin p 32
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 94 95 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 100 101 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 135 136 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 220 221 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 226 227 214 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 232 234 216 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 449 450 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 455 456 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 461 463 437 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 697 698 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 703 704 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 709 711 677 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 794 795 762 763 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 800 801 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 806 808 766 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Nevertheless, findings from this study allow us to propose the following mechanism of Cavalpha2delta1-mediated tactile allodynia (Fig. 7): At the resting state under normal synaptic functions, the expression levels of Cavalpha2delta1 in large DRG neurons and A-fiber terminals are relatively low, so as the rate of quanta glutamate release from A-fiber terminals that maintains a normal neuronal excitation threshold to innocuous stimulation. The Cavalpha2delta1 expression levels in small DRG neurons and C-fiber terminals are relatively high, but may have little effect on glutamate release from C-fiber terminals at a resting state due to the lack of C-fiber inputs. This high level of basal Cavalpha2delta1 expression in small DRG neurons may set up a ceiling effect for the influence of Cavalpha2delta1 on WDR neuron excitability to C-fiber or windup stimulations (discussed below).
###end p 32
###begin p 33
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
Mild pre-synaptic membrane depolarization in response to an action potential leads to the opening of VGCC, triggering calcium influx and a quantum release of excitatory neurotransmitter glutamate. Binding of glutamate to post-synaptic AMPA receptors at a resting state causes a conformational change of the receptors that is linked to channel opening, which is terminated by desensitization of the receptors [33]. In addition, glutamate activation of kainate receptors at the pre-synaptic sensory neuron terminals can reduce glutamate release [34], and that at spinal interneurons can induce inhibitory transmitter release [35]. This heterosynaptic regulation, which is transient due to kainate receptor desensitization, also plays a role in terminating transient activation of post-synaptic dorsal horn neurons under normal physiological conditions [35]. Under normal physiological conditions, released glutamate is insufficient in activating post-synaptic NMDA receptors (Fig. 7A).
###end p 33
###begin p 34
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 56 57 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 62 64 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 164 165 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 170 171 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 176 178 160 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1015 1017 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 1230 1231 1214 1215 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1236 1237 1216 1217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1242 1244 1218 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
After peripheral nerve injuries, injury-induced Cavalpha2delta1 upregulation in DRG neurons, more so in large DRG neurons, leads to increased axonal transport of Cavalpha2delta1 proteins to central pre-synaptic terminals, which in turn causes an increased rate of basal release of glutamate through a yet identified mechanism. This "glutamate leaking" causes partial sensitization of deep dorsal horn neurons by activating mainly AMPA/kainate receptors at the resting state. These "sensitized" dorsal horn neurons therefore have lowered excitation thresholds to a subsequent release of glutamate in response to innocuous or mild nociceptive stimuli that could evoke further conformational change of the AMPA/kainate receptors and prolonged channel opening, leading to spinal hyperexcitability. In addition, signals of mild noxious stimulation could be further amplified in these sensitized dorsal horn neurons due to their low thresholds to NMDA receptor activation, leading to exaggerated painful sensations (Fig. 7B). These hyperexcitability states are sensitive to antagonists of AMPA/kainate and NMDA receptors. However, neither the partial neuron sensitization by glutamate leaking from A-fiber terminals nor the increased Cavalpha2delta1 expression in C-fiber terminals has any detectable effect on WDR neuron excitability to high intensity C-fiber stimulations (the ceiling effect discussed above).
###end p 34
###begin p 35
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 53 54 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 59 60 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 130 132 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 176 177 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 182 183 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 188 190 172 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 264 266 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 267 269 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 366 367 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 372 373 352 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 378 380 354 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 595 608 571 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v&#945;2&#948; </sub>
###xml 730 732 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 995 997 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1038 1039 1006 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1044 1045 1008 1009 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1050 1052 1010 1012 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
The detail mechanisms regarding how elevated Cavalpha2delta1mediates enhanced pre-synaptic glutamate release remain elusive (Fig. 7C). Based on in vitro data indicating that Cavalpha2delta1 expression is required for normal membrane expression of functional VGCC [36-40], which is critical in mediating pre-synaptic neurotransmission, it is possible that elevated Cavalpha2delta1 leads to an enhanced VGCC expression at the pre-synaptic terminals. However, there is no direct evidence so far to support this hypothesis. Alternatively, recent findings in drosophila point to the direction that Cavalpha2delta plays a critical role in formation of pre-synaptic structures and active zones related to pre-synaptic neurotransmission [41]. Indeed, it has been proposed that the ability of descending excitatory 5HT3 mediated projections to induce a state-dependency in the actions of gabapentin may also occur with the monoamine receptor interacting with pre-synaptic mechanisms at the spinal level [16]. Thus, it is possible that increased Cavalpha2delta1 causes enhanced synaptic strength and/or synapse numbers by promoting formation of more active zones through a yet identified mechanism. These two possibilities may not be mutually exclusive, and deserve further investigation.
###end p 35
###begin title 36
Conclusion
###end title 36
###begin p 37
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 70 71 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 76 78 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 429 430 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 435 436 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 441 443 425 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
In conclusion, findings from this study support that elevated Cavalpha2delta1 causes spinal hypersensitivity and tactile allodynia through at least partially enhanced pre-synaptic glutamate release, which may lead to sensitization of post-synaptic dorsal horn neurons by lowering their thresholds to innocuous stimuli. This spinal sensitization may contribute to the neuropathic pain states derived from increased pre-synaptic Cavalpha2delta1 expression.
###end p 37
###begin title 38
Methods
###end title 38
###begin title 39
Animals
###end title 39
###begin p 40
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 44 45 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 50 52 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 126 127 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 132 133 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 138 140 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 204 212 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thy-1.2 </italic>
###xml 344 346 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 462 464 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 577 579 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 857 858 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
###xml 197 203 <span type="species:ncbi:10090">murine</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
Transgenic mice over-expressing the Cavalpha2delta1 gene were generated with a transgenic vector containing the mouse brain Cavalpha2delta1 cDNA (Genbank accession number ) down-stream of a 6.5 kb murine thy-1.2 gene extending from the promoter region to the intron after exon 4 without exon 3 and its flanking introns as described previously [42]. Thy-1 is a member of the immunoglobulin superfamily that is expressed in both neuronal and non-neuronal tissues [43], and deletion of exon 3 and its flanking introns has been shown to eliminate expression in non-neuronal cells [44]. Only adult male TG mice and their WT littermates were used for the experiments. All the mice were fertile, appeared normal with respect to grooming, social interactions and feeding, and showed no signs of abnormality or any obvious motor defects, tremor, seizure, or ataxia [8].
###end p 40
###begin p 41
All animal care and experimental procedures were performed based on protocols approved by the Institutional Animal Care Committees of the University of California, Irvine, University College London and Indiana University.
###end p 41
###begin title 42
Neuropathic lesions
###end title 42
###begin p 43
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
The surgical procedure of SNL was performed as described [45]. Briefly, under isoflurane anesthesia, the left L5 spinal nerve of mice were exposed and ligated with a silk suture distal to DRG and proximal to their conjunction to form the sciatic nerve. Sham operations were performed in the same way except that spinal nerves were not ligated.
###end p 43
###begin title 44
Behavioral assays
###end title 44
###begin p 45
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 866 867 866 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1288 1289 1288 1289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">v</sub>
###xml 1294 1295 1290 1291 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1300 1302 1292 1294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 1171 1176 <span type="species:ncbi:10090">mouse</span>
###xml 1305 1309 <span type="species:ncbi:10090">mice</span>
###xml 1390 1394 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
Behavioral response to mechanical stimulation was tested blindly as described before and post drug treatments [8]. Briefly, mice were allowed to acclimatize for 1 hr in a clear plastic cage with a wire mesh bottom. The 50% paw withdrawal thresholds (PWT) to calibrated von Frey filament (Stoelting, Wood Dale, IL) stimulation were determined using a modified up-down method of Dixon [46]. A series of filaments, starting with one that has a buckling weight of 0.41 g, were applied in consecutive sequence to the plantar surface of the left hindpaw with a pressure causing the filament to buckle. Paw lifting within 5 s was considered a positive response and led to the use of the next weaker filament. Absence of a paw lifting after 5 s led to the use of the next filament with increasing weight. The 50% paw withdrawal threshold was calculated as described before [2] from the resulting scores of six measurements starting from the one prior to the first positive response; or until four consecutive positive (assigned a score of 0.01 g) or five consecutive negative (assigned a score of 3 g) responses had occurred. Paw withdrawal thresholds from each hindpaw of a SNL mouse were recorded separately, or averaged paw withdrawal thresholds from both hindpaws of the WT and injury-free Cavalpha2delta1 TG mice were used for comparing sensitivities between injury and non-injury side in SNL mice or between injury-free WT and TG mice, respectively, with or without drug treatment.
###end p 45
###begin title 46
Drug administration
###end title 46
###begin p 47
###xml 127 129 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
Drug working solutions were prepared in sterile saline before intrathecal injections between lumbar regions 5-6 (5 muL/mouse) [47]. In some cases that multiple drugs were used in the same group of animals, a three-day drug-free period was introduced between each drug to ensure that the previous drug was completely out, even though all the drug effects in this study were terminated within 24 hr post injection.
###end p 47
###begin title 48
Electrophysiological recordings in dorsal horn neurons in vivo
###end title 48
###begin p 49
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Recordings were performed by examiners blinded to the mouse genotype. Animals were placed in a stereotaxic frame under anesthesia and the L3-L6 spinal segments were exposed with a laminectomy. Extracellular recordings were made from individual wide dynamic range neurons using parylene coated tungsten electrodes (A-M Systems, USA). Neurons were visualized, isolated, and discriminated based on their spike amplitudes and waveforms. All neurons used for recording had receptive fields over the hindpaw. Depth of the neuron was measured from the surface of the spinal cord. Spontaneous activity was quantified over a period of at least 100 s in the absence of any evoked stimulus on isolation of a neuron.
###end p 49
###begin p 50
Electrical stimulation was given via two needles inserted into the receptive field and the evoked activity was characterized and quantified as follows. A train of 16 stimuli was given (2 ms pulse duration, 0.5 Hz at three-times the C-fiber threshold), and the evoked neuronal responses were quantified using online analysis (Spike 2 software, CED Cambridge UK). The evoked neuronal responses were superimposed as a post-stimulus histogram and responses identified - based on fiber conduction velocity and the resulting latency - as C-fiber-evoked (50-250 msec) action potentials. Neuronal responses occurring after the C-fiber latency band of the neuron (250-800 ms) were classed as post discharge. The 'input' (non-potentiated response) was determined as: Input = [action potentials (50-800 ms) evoked by first pulse at 3 times C-fiber threshold] x total number of pulses.
###end p 50
###begin title 51
Electrophysiological recordings in dorsal horn of spinal cord slices
###end title 51
###begin p 52
###xml 399 400 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 419 420 412 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 422 423 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 433 434 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 443 444 436 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 505 507 498 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 516 517 509 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 633 634 626 627 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 642 643 635 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 653 654 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 656 657 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 667 668 660 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 759 761 752 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 770 771 763 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1119 1120 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1137 1138 1126 1127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Recordings were performed by examiners blinded to the mouse genotype. The animals were anesthetized with ketamine-HCl (1 mg/kg, i.p.) and the spinal cord was extracted by hydraulic extrusion. Transverse slices (330 mum) were cut from the L5 lumbar enlargement using a vibratome (VT1000S; Leica, Nussloch, Germany) in an ice-cold (4degreesC) sucrose solution containing (in mM): 230 sucrose, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 10 MgSO4, 10 glucose, pH 7.4, 290-305 mOsm/L, equilibrated with 95% O2 and 5% CO2. The slices were maintained in an artificial cerebrospinal fluid (ACSF) containing (in mM): 130 NaCl, 3 KCl, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose, pH 7.4, 295-305 mOsm/L. The ACSF was continuously equilibrated with 95% O2 and 5% CO2, and slices were incubated for > 1 h before recording. Recording electrodes were prepared from borosilicate glass (World Precision Instruments, Sarasota, FL) using a horizontal electrode puller (P-97; Sutter Instruments, Novato, CA). Electrodes had resistances of 2-4 MOmega when filled with an intracellular solution containing (in mM): 92 CsMeSO4, 43 CsCl, 1 MgCl2, 2 EGTA, 5 TEA, 10 HEPES and 2 Mg-ATP, pH 7.4, 295-300 mOsm/L. Oxygenated ACSF was used as bath solution, and the flow rate was adjusted to 2-3 mL/min. Depth of the neuron was measured from the surface of the spinal cord and neurons in the deep dorsal horn were visualized with an infrared-differential interference contrast (DIC) microscope (BX50WI; Olympus Optical, Tokyo, Japan) and a CCD camera. All recordings were performed at 25 +/- 1degreesC with an Axopatch 200B amplifier (Molecular Devices, Foster City, CA). During whole-cell recordings, series resistance (8-15 MOmega) was monitored periodically, and cells with > 15% changes were excluded from the analysis. Signals were filtered at 1 kHz and digitized at a sampling rate of 5 kHz using a data-acquisition program (Axograph 4.6; Molecular Devices).
###end p 52
###begin p 53
To record mEPSCs, tetrodotoxin (1 muM) and bicuculline (30 muM) were continuously applied in the bath solution. At a holding potential of -70 mV, the recorded mEPSCs were mainly mediated by AMPA/kainate receptors because application of AMPA/kainate receptor antagonist CNQX (10 muM) could reduce mEPSCs by 91.3 +/- 5.3% and 93.9 +/- 3.3% in WT and TG neurons (n = 5 in each group), respectively. In the presence of CNQX (10 muM), NMDA receptor-mediated mEPSCs were recorded at a holding potential of +50 mV.
###end p 53
###begin title 54
Statistical Analyses
###end title 54
###begin p 55
###xml 61 63 61 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 108 110 108 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
Indicated significant changes were defined by the two-tailed p values as determined with unpaired Student's t test, or two-way ANOVA followed by Bonferroni post-tests.
###end p 55
###begin title 56
Competing interests
###end title 56
###begin p 57
The authors declare that they have no competing interests.
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
###xml 455 470 <span type="species:ncbi:10090">transgenic mice</span>
DN participated in the design, carried out the behavioral pharmacology studies, and participated in drafting the manuscript. PD participated in the design and carried out the electrophysiology studies in spinal cord slices. EAM participated in the design and carried out the electrophysiology studies in dorsal horn neurons in vivo. DSK participated in the experimental design and animal model studies. GF participated in the design and generation of the transgenic mice. AHD participated in the experimental design, coordination and data analysis of the in vivo electrophysiology studies, and in drafting the manuscript. ZCX participated in the experimental design, coordination and data analysis of the electrophysiology studies in spinal cord slices, and in drafting the manuscript. ZDL conceived of the study and participated in its design, coordination and drafted the manuscript. All authors read and approved the final manuscript.
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
###xml 90 97 <span type="species:ncbi:15957">Timothy</span>
###xml 140 155 <span type="species:ncbi:10090">transgenic mice</span>
Supported in part by NIH grants: NS40135, DE14545 (Z. D. Luo). We would like to thank Mr. Timothy Yolo for his assistant in maintaining the transgenic mice. David Nguyen was supported by a Medical Student Anesthesia Research Fellowship from the Foundation for Anesthesia Education and Research.
###end p 61
###begin article-title 62
"Virtual textbook" on pain developed: effort seeks to remedy gap in medical education
###end article-title 62
###begin article-title 63
###xml 136 140 <span type="species:ncbi:10116">rats</span>
Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats
###end article-title 63
###begin article-title 64
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin
###end article-title 64
###begin article-title 65
Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury
###end article-title 65
###begin article-title 66
Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases
###end article-title 66
###begin article-title 67
###xml 32 35 <span type="species:ncbi:10116">rat</span>
Coupling gene chip analyses and rat genetic variances in identifying potential target genes that may contribute to neuropathic allodynia development
###end article-title 67
###begin article-title 68
Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia
###end article-title 68
###begin article-title 69
Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation
###end article-title 69
###begin article-title 70
The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel
###end article-title 70
###begin article-title 71
###xml 116 119 <span type="species:ncbi:10116">rat</span>
Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat
###end article-title 71
###begin article-title 72
###xml 76 79 <span type="species:ncbi:10116">rat</span>
The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain
###end article-title 72
###begin article-title 73
###xml 159 162 <span type="species:ncbi:10116">rat</span>
Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat
###end article-title 73
###begin article-title 74
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial [see comments]
###end article-title 74
###begin article-title 75
Gabapentin adjunctive therapy in neuropathic pain states
###end article-title 75
###begin article-title 76
The effect of gabapentin on neuropathic pain
###end article-title 76
###begin article-title 77
Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin
###end article-title 77
###begin article-title 78
###xml 110 113 <span type="species:ncbi:10116">rat</span>
Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat
###end article-title 78
###begin article-title 79
###xml 115 119 <span type="species:ncbi:10116">rats</span>
Enhancement of NMDA receptor phosphorylation of the spinal dorsal horn and nucleus gracilis neurons in neuropathic rats
###end article-title 79
###begin article-title 80
Ca2+ channels and synaptic transmission at the adult, neonatal, and P/Q-type deficient neuromuscular junction
###end article-title 80
###begin article-title 81
Spinal plasticity mediated by postsynaptic L-type Ca2+ channels
###end article-title 81
###begin article-title 82
###xml 41 44 <span type="species:ncbi:10116">rat</span>
Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals
###end article-title 82
###begin article-title 83
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Algogen-specific pain processing in mouse spinal cord: differential involvement of voltage-dependent Ca(2+) channels in synaptic transmission
###end article-title 83
###begin article-title 84
###xml 129 132 <span type="species:ncbi:10116">rat</span>
Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy
###end article-title 84
###begin article-title 85
Presynaptic Ca2+ channels: a functional patchwork
###end article-title 85
###begin article-title 86
Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels
###end article-title 86
###begin article-title 87
Central sensitization and LTP: do pain and memory share similar mechanisms?
###end article-title 87
###begin article-title 88
###xml 163 167 <span type="species:ncbi:10116">rats</span>
Role of protein kinase A in phosphorylation of NMDA receptor 1 subunits in dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats
###end article-title 88
###begin article-title 89
###xml 83 87 <span type="species:ncbi:10116">rats</span>
Protein phosphatase modulates the phosphorylation of spinal cord NMDA receptors in rats following intradermal injection of capsaicin
###end article-title 89
###begin article-title 90
Silent glutamatergic synapses and nociception in mammalian spinal cord
###end article-title 90
###begin article-title 91
###xml 23 26 <span type="species:ncbi:10116">rat</span>
Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury
###end article-title 91
###begin article-title 92
Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics
###end article-title 92
###begin article-title 93
###xml 75 79 <span type="species:ncbi:10116">rats</span>
An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy
###end article-title 93
###begin article-title 94
Mechanism of glutamate receptor desensitization
###end article-title 94
###begin article-title 95
Presynaptic kainate receptors regulate spinal sensory transmission
###end article-title 95
###begin article-title 96
Direct presynaptic regulation of GABA/glycine release by kainate receptors in the dorsal horn: An ionotropic mechanism
###end article-title 96
###begin article-title 97
Extracellular interaction of the voltage-dependent Ca2+ channel alpha2delta and alpha1 subunits
###end article-title 97
###begin article-title 98
Dual function of the voltage-dependent Ca2+ channel alpha 2 delta subunit in current stimulation and subunit interaction
###end article-title 98
###begin article-title 99
Dissection of functional domains of the voltage-dependent Ca2+ channel alpha2delta subunit
###end article-title 99
###begin article-title 100
The alpha 2/delta subunit of voltage sensitive Ca2+ channels is a single transmembrane extracellular protein which is involved in regulated secretion
###end article-title 100
###begin article-title 101
###xml 86 91 <span type="species:ncbi:9606">human</span>
Structure and functional expression of alpha 1, alpha 2, and beta subunits of a novel human neuronal calcium channel subtype
###end article-title 101
###begin article-title 102
###xml 15 25 <span type="species:ncbi:7227">Drosophila</span>
Mutations in a Drosophila alpha2delta voltage-gated calcium channel subunit reveal a crucial synaptic function
###end article-title 102
###begin article-title 103
###xml 39 43 <span type="species:ncbi:10090">Mice</span>
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
###end article-title 103
###begin article-title 104
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
Regulation of Thy-1 gene expression in transgenic mice
###end article-title 104
###begin article-title 105
Tissue-specific control elements of the Thy-1 gene
###end article-title 105
###begin article-title 106
###xml 99 102 <span type="species:ncbi:10116">rat</span>
An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
###end article-title 106
###begin article-title 107
Efficient analysis of experimental observations
###end article-title 107
###begin article-title 108
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling
###end article-title 108

